InvestorsHub Logo
Followers 0
Posts 91
Boards Moderated 0
Alias Born 02/18/2017

Re: Aston Martin post# 13123

Sunday, 04/09/2017 11:17:41 AM

Sunday, April 09, 2017 11:17:41 AM

Post# of 34296
The Duffields' loyalty is to the Senteeko Tea Estate. PLPL and now TXTM shareholders are secondary or tertiary concerns, at best. I don't know Senteeko's fiscal burn rate, but it isn't pulling its weight. They have what, 300 employees? TXTM has suffered a billion shares of fresh dilution since the Duffields came in. What did it get? Two subsidiaries, Senteeko and Cannabis Biosciences. What will happen when the TXTM milker dries up? I foresee that Cannabis Biosciences will have an IPO under its own ticker. Its product will be PhytoPot, which will cure diabetes, obesity, cancer and Alzheimer's. It'll be almost as effective as drinking the juice of freshly-juiced cannabis plants, which anyone can do for free after legalization with no Cannabis Biosciences capsules required. But the existence of an efficacious home remedy doesn't preclude success selling to those who lack gardens or knowledge. So TXTM shareholders have two subsidiaries now, but when the Cannabis Biosciences subsidiary leaves the nest, and for its first transaction buys the Senteeko Tea Estate subsidiary for stock, will have what PLPL shareholders now have. Wash rinse repeat.